Stockscreener 앱 받기
4.92
13.23%
-0.75
시장 영업 전:
4.95
0.03
+0.61%
Bioxcel Therapeutics Inc (BTAI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
28.57%
0.12
|
0.168 | 0.366 | 0.214 | 1.104 |
| Cost Of Revenue |
664.29%
0.107
|
0.014 | 0.832 | 1.17 | 0.062 |
| Gross Profit |
91.56%
0.013
|
0.154 | -0.466 | -0.956 | 1.042 |
Operating Expenses
|
54.74%
15.87
|
10.25 | 10.03 | 14.34 | 18.34 |
| Benefits Costs and Expenses |
115.20%
15.97
|
7.422 | 11.22 | 15.51 | 18.40 |
| Costs And Expenses |
55.57%
15.97
|
10.27 | 10.86 | 15.51 | 18.40 |
| Operating Income/Loss |
56.97%
-15.85
|
-10.10 | -10.49 | -15.29 | -17.30 |
| Income/Loss From Continuing Operations Before Tax |
118.53%
-15.85
|
-7.254 | -10.86 | -15.29 | -8.299 |
| Income/Loss From Continuing Operations After Tax |
164.50%
-19.19
|
-7.254 | -10.86 | -13.65 | -8.299 |
|
Net Income/Loss
|
164.50%
-19.19
|
-7.254 | -10.86 | -13.65 | -8.299 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
62.25%
7.843
|
4.834 | -35.32 | 42.39 | 40.25 |
| Diluted Average Shares |
62.25%
7.843
|
4.834 | -35.32 | 42.39 | 40.25 |
| Basic Earnings Per Share |
63.33%
-2.45
|
-1.50 | -22.22 | -0.32 | -0.21 |
| Diluted Earnings Per Share |
63.33%
-2.45
|
-1.50 | -22.22 | -0.32 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.22%
3.58%
자본화:
|
볼륨(24시간):